Prostate Cancer - Results from #28260

Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 Study - Abstract May 10, 2011

The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer - Abstract May 10, 2011

Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis - Abstract May 10, 2011

Current status of pelvic lymph node dissection in prostate cancer: The New York PLND nomogram - Abstract May 10, 2011

Adjuvant radiation treatment after prostatectomy. Where do we stand? - Abstract May 10, 2011

ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: Evidence supporting monoclonal origin - Abstract May 10, 2011

EAU 2011 - Vas deferens suspension improves early urine continence after RALP: A randomized analysis - Session Highlights May 10, 2011

EAU 2011 - Pathologic stage at prostatectomy over time: Has there been a trend toward intervention for localized disease in the robotic era? - Session Highlights May 10, 2011

EAU 2011 - Radical prostatectomy in men with continuous oral aspirin medication: Revisiting old paradigm? - Session Highlights May 10, 2011

EAU 2011 - Differences in biochemical recurrence rate after focal and extensive positive surgical margins following radical prostatectomy - Session Highlights May 10, 2011

Oxidative stress measured by urine F2-Isoprostane level is associated with prostate cancer - Abstract May 9, 2011

Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer - Abstract May 9, 2011

Trends in mortality from urologic cancers in Europe, 1970-2008 - Abstract May 9, 2011

The CT flare response of metastatic bone disease in prostate cancer - Abstract May 9, 2011

In vivo imaging of intraprostatic-specific gene transcription by PET - Abstract May 9, 2011

Prolonged response to early docetaxel in a patient with biochemical relapse after primary therapy for prostate cancer and incomplete response to androgen suppression therapy - Abstract May 9, 2011

Statins and prostate cancer diagnosis and grade in a veterans population - Abstract May 9, 2011

Investigative clinical study on prostate cancer part v: Luteinizing hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population - Abstract May 9, 2011

BJUI Mini Reviews - Evidence-based medicine: Comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate May 9, 2011

EAU 2011 - Clinical benefit of cabazitaxel plus prednisone in the TROPIC trial in men with metastatic castration resistant prostate cancer (mCRPC) who progressed after docetaxel-based treatment - Session Highlights May 9, 2011

Page 1414 of 1447